RB1 and breast carcinoma: Others have reported that overexpression of AP-2α inhibits breast cancer cell growth by inducing the expression of the cell cycle inhibitor p21, repressing cyclin D1, decreasing Rb phosphorylation, and by enhancing E2F activity [29].